Atlas Trials

Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough

Clinical trial NCT06504446 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06504446
Sponsor
Nocion Therapeutics
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Refractory or Unexplained Chronic Cough
Start date
2024-09-24
Primary completion
2026-06-15
Enrollment
455

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.